Utano, Kenichi
Takayanagi, Daisuke
Nagata, Koichi
Aizawa, Masato
Endo, Shungo
Nemoto, Tetsutaro
Nemoto, Daiki
Isohata, Noriyuki
Lefor, Alan Kawarai
Togashi, Kazutomo https://orcid.org/0000-0002-4080-5335
Funding for this research was provided by:
Ajinomoto Pharmaceuticals
Article History
Received: 29 October 2018
Revised: 10 February 2019
Accepted: 25 February 2019
First Online: 22 March 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is Kazutomo Togashi (corresponding author).
: The authors of this manuscript declare relationships with the company EA Pharma Co., Ltd., Tokyo, Japan.
: Professor Yoshikazu Nakamura (Department of Public Health, Jichi Medical University) kindly provided the statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional review board approval was obtained.
: • prospective• randomized controlled trial• performed at one institution